Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
Crossref DOI link: https://doi.org/10.1007/s40267-018-0542-y
Published Online: 2018-08-06
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyseng-Williamson, Katherine A. https://orcid.org/0000-0002-5104-1158
Behr, Jürgen
Text and Data Mining valid from 2018-08-06
Article History
First Online: 6 August 2018